G. Hasselgren

发表

A randomized, comparative study of three doses of AZD0865 and esomeprazole for healing of reflux esophagitis.

P. Malfertheiner, J. Dent, P. Kahrilas, 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Pharmacokinetic study of esomeprazole in patients with hepatic impairment

E. Björnsson, H. Sjövall, K. Röhss, 2002, European journal of gastroenterology & hepatology.

Pharmacokinetic Studies with Esomeprazole, the (S)-Isomer of Omeprazole

T. Andersson, K. Röhss, G. Hasselgren, 2001, Clinical pharmacokinetics.

Pharmacokinetic Study of Esomeprazole in the Elderly

T. Andersson, K. Röhss, G. Hasselgren, 2001, Clinical pharmacokinetics.

Drug Interaction Studies with Esomeprazole, the (S)-Isomer of Omeprazole

T. Andersson, K. Röhss, G. Hasselgren, 2001, Clinical pharmacokinetics.

Pharmacokinetics of Omeprazole Given by Continuous Intravenous Infusion to Patients with Varying Degrees of Hepatic Dysfunction

J. Piqué, K. Röhss, G. Hasselgren, 2002, Clinical pharmacokinetics.

One‐week triple therapy with esomeprazole provides effective eradication of Helicobacter pylori in duodenal ulcer disease

K. Lauritsen, S. Veldhuyzen van Zanten, T. Lind, 2000, Alimentary pharmacology & therapeutics.

Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months

N. Talley, D. Armstrong, K. Bardhan, 2002, European journal of gastroenterology & hepatology.

The effect of the area under the plasma concentration vs time curve and the maximum plasma concentration of esomeprazole on intragastric pH

O. Junghard, G. Hasselgren, M. Hassan-Alin, 2002, European Journal of Clinical Pharmacology.

Studies in Healthy Volunteers do not Show any Electrocardiographic Effects with Esomeprazole

E. Svernhage, G. Hasselgren, M. Niazi, 2000 .

One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease

Z. Tulassay, P. Dítě, Z. Bartuzi, 2001, European journal of gastroenterology & hepatology.

Overall mortality among patients surviving an episode of peptic ulcer bleeding

M. Wallander, S. Johansson, A. Ruigómez, 2000, Journal of epidemiology and community health.

Short and long term course of elderly patients with peptic ulcer bleeding--analysis of factors influencing fatal outcome.

L. Lundell, S. Eriksson, G. Hasselgren, 2003, The European journal of surgery = Acta chirurgica.

Risk factors for rebleeding and fatal outcome in elderly patients with acute peptic ulcer bleeding.

L. Lundell, O. B. Schaffalitzky de Muckadell, T. Lind, 1998, European journal of gastroenterology & hepatology.

Comparison of Mortality from Peptic Ulcer Bleed between Patients with or without Peptic Ulcer Antecedents

M. Wallander, S. Johansson, L. G. García Rodríguez, 1998, Epidemiology.

Optimization of acid suppression for patients with peptic ulcer bleeding: an intragastric pH‐metry study with omeprazole

K. Röhss, G. Hasselgren, P. Sinclair, 1998, European journal of gastroenterology & hepatology.

Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre study.

H. Harling, O. B. Schaffalitzky de Muckadell, T. Havelund, 1997, Scandinavian journal of gastroenterology.

Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study.

L. Lundell, S. Eriksson, E. Aadland, 1997, Scandinavian journal of gastroenterology.

7-day treatment with esomeprazole-based triple therapy eradicates H. pylori (Hp) and heals patients with duodenal ulcer (DU) disease

Z. Tulassay, P. Dítě, G. Hasselgren, 2000 .

7-day triple therapy with esomeprazole, amoxicillin and clarithromycin for H. pylori (Hp) eradication in duodenal ulcer (DU) disease

K. Lauritsen, T. Lind, J. Labenz, 2000 .

Peptic Ulcer Bleeding Towards Improved Outcome by Göran Hasselgren Göteborg 1998

G. Hasselgren, BlOMEDiCINSKA Biblioteket, Peptic Ulcer Bleeding, 2015 .

Effect of Esomeprazole 40 mg vs Omeprazole 40 mg on 24-Hour Intragastric pH in Patients with Symptoms of Gastroesophageal Reflux Disease

H. Hedenström, K. Röhss, G. Hasselgren, 2002, Digestive Diseases and Sciences.

Occurrence of nighttime gastroesophageal reflux in disturbed and normal sleepers.

W. Orr, S. Goodrich, G. Hasselgren, 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Esomeprazole 40 Mg provides more effective acid control than standard doses of all other proton pump inhibitors

C. Wilder-Smith, K. Röhss, G. Hasselgren, 2001 .

Bone grafting unnecessary in the treatment of enchondromas in the hand.

G. Hasselgren, A. Törnvall, G. Hasselgren, 1991, The Journal of hand surgery.

Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastro‐oesophageal reflux disease

K. Röhss, G. Hasselgren, Lind, 2000, Alimentary pharmacology & therapeutics.